The store will not work correctly when cookies are disabled.
6-(4-fluorophenethyl)-4-hydroxypyridazin-3(2H)-one
ID: ALA2338800
PubChem CID: 71270282
Max Phase: Preclinical
Molecular Formula: C12H11FN2O2
Molecular Weight: 234.23
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1[nH]nc(CCc2ccc(F)cc2)cc1O
Standard InChI: InChI=1S/C12H11FN2O2/c13-9-4-1-8(2-5-9)3-6-10-7-11(16)12(17)15-14-10/h1-2,4-5,7H,3,6H2,(H,14,16)(H,15,17)
Standard InChI Key: VXMITFXRZIEUCJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
17 18 0 0 0 0 0 0 0 0999 V2000
2.3383 -1.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -2.7000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0031 3.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3039 3.7494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3070 5.2502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6061 6.0003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6061 7.5003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3071 8.2503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3071 9.4503 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-0.0080 7.5003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0080 6.0003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 1 0
7 2 1 0
7 8 2 0
4 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
14 16 1 0
16 17 2 0
17 11 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 234.23 | Molecular Weight (Monoisotopic): 234.0805 | AlogP: 1.40 | #Rotatable Bonds: 3 |
Polar Surface Area: 65.98 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.57 | CX Basic pKa: ┄ | CX LogP: 1.88 | CX LogD: 1.65 |
Aromatic Rings: 2 | Heavy Atoms: 17 | QED Weighted: 0.84 | Np Likeness Score: -0.92 |
References
1. Hondo T, Warizaya M, Niimi T, Namatame I, Yamaguchi T, Nakanishi K, Hamajima T, Harada K, Sakashita H, Matsumoto Y, Orita M, Takeuchi M.. (2013) 4-Hydroxypyridazin-3(2H)-one derivatives as novel D-amino acid oxidase inhibitors., 56 (9): [PMID:23566269] [10.1021/jm400095b] |
2. (2015) Dihydroxy aromatic heterocyclic compound, |
3. (2016) Pyridazinone compounds and their use as DAAO inhibitors, |